Suppliers / Mc2 Therapeutics

Mc2 Therapeutics

Denmark 19 employees Updated 9 July 2026

Mc2 Therapeutics is a finished-dose manufacturer based in Denmark. It appears in 1 regulatory filing across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
1
filings across 1 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 1 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Mc2 Therapeutics

Does Mc2 Therapeutics hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Mc2 Therapeutics. It does have 1 filing with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Mc2 Therapeutics file?
Filings are on record with US FDA, 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Mc2 Therapeutics comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Novo Nordisk A/S also in Denmark SmartPractice Denmark ApS also in Denmark Danipharm A/S also in Denmark H. Lundbecks A/S also in Denmark Syntese A/S also in Denmark

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability